ResearchOctober 3, 2026
Retatrutide Phase 3 Results: Weight Loss, Knee Pain, and Sleep Apnea
TRIUMPH-1 reported average weight reduction of up to 25% at 80 weeks, alongside knee-pain and sleep-apnea improvements. What the trial does—and does not—establish.
Read article

